The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
The Diabetes Management - Basic panel contains 3 tests with 25 biomarkers.
Brief Description: The Diabetes Management - Basic panel is a fundamental tool designed to help monitor and manage diabetes effectively. This panel includes a series of tests that provide a comprehensive overview of a patient's metabolic status, blood glucose control, and kidney function. By assessing these key markers, healthcare providers can evaluate the current state of a patient's diabetes, identify potential complications early, and adjust treatment plans to ensure optimal management of the disease.
Collection Method: Blood Draw and Urine Collection
Specimen Type: Whole Blood, Serum, and Urine
Test Preparation: Fasting specimen is preferred
The Diabetes Management - Basic panel may be ordered for individuals diagnosed with diabetes to monitor their disease progression and management. It is also useful for those at risk of developing diabetes, such as individuals with a family history of diabetes, obesity, or other metabolic risk factors. This panel helps to track the effectiveness of current treatment plans, detect complications early, and make necessary adjustments to improve patient outcomes.
The Diabetes Management - Basic panel includes the following tests, each providing critical information about a patient's health:
The Comprehensive Metabolic Panel (CMP) evaluates various components of blood chemistry to assess kidney and liver function, electrolyte balance, and glucose levels. This test helps in detecting potential complications related to diabetes, such as kidney damage or liver issues.
Hemoglobin A1c (HbA1c) measures the average blood glucose concentration over the past two to three months. It is a crucial marker for long-term glucose control, helping to determine how well a patient's diabetes is being managed and if any changes in treatment are necessary.
Microalbumin, Random Urine with Creatinine
This test measures the amount of albumin in the urine, which can indicate kidney damage. The inclusion of creatinine helps to account for variations in urine concentration. Detecting microalbuminuria early is vital for preventing the progression of diabetic nephropathy.
For individuals seeking a more detailed understanding of their health, the following panels offer expanded testing that provides additional insights beyond the basic panel:
The Basic Plus panel adds a Complete Blood Count with Differential and Platelets and a Lipid Panel with Ratios. This expansion provides insights into overall blood health and cholesterol levels, which are important for cardiovascular health in diabetes management.
The Advanced panel includes everything in the Basic Plus panel, with the addition of Cystatin C and Insulin tests. Cystatin C is a marker of kidney function that can detect early kidney disease, while the insulin test helps evaluate insulin production and resistance, providing a deeper understanding of diabetes management.
The Comprehensive panel is the most detailed option, including all tests from the Advanced panel plus Apolipoprotein A1, Apolipoprotein B, and C-Reactive Protein. These additional tests offer detailed insights into cardiovascular risk and inflammation, crucial for comprehensive diabetes care.
The Diabetes Management - Basic panel is instrumental in detecting and monitoring several conditions associated with diabetes:
Diabetes Mellitus
Diabetes Mellitus is a chronic condition characterized by high blood glucose levels. The Hemoglobin A1c test in the panel is crucial for diagnosing and monitoring diabetes by providing an average of blood glucose levels over time.
Diabetic Nephropathy
This is a kidney disease resulting from diabetes. The Microalbumin, Random Urine with Creatinine test helps detect early signs of kidney damage, allowing for timely intervention to prevent further progression.
Diabetes Mellitus
Healthcare professionals use Hemoglobin A1c results to assess how well a patient’s blood glucose levels are controlled. Based on these results, they can adjust medications, recommend dietary changes, or modify other aspects of the treatment plan to better manage diabetes.
Diabetic Nephropathy
The detection of microalbumin in the urine indicates early kidney damage. Healthcare providers use these results to implement strategies to protect kidney function, such as controlling blood pressure and glucose levels more tightly, and possibly prescribing medications to reduce kidney strain.
The Diabetes Management - Basic panel is a vital tool for monitoring and managing diabetes. By providing key insights into glucose control, kidney function, and overall metabolic health, this panel helps healthcare providers develop and adjust treatment plans to improve patient outcomes. Regular monitoring through this panel allows for early detection of complications, ensuring that patients receive timely and effective care to manage their diabetes and maintain their health.